Transcatheter aortic valve implantation under 75 years of age: only for high surgical risk patients; but for how long?
- PMID: 39210080
- PMCID: PMC11413247
- DOI: 10.1007/s12471-024-01900-9
Transcatheter aortic valve implantation under 75 years of age: only for high surgical risk patients; but for how long?
Conflict of interest statement
M. Voskuil and M.G. Dickinson declare that they have no competing interests.
Similar articles
-
Postoperative delirium and quality of life after transcatheter and surgical aortic valve replacement: A prospective observational study.J Thorac Cardiovasc Surg. 2023 Jul;166(1):156-166.e6. doi: 10.1016/j.jtcvs.2021.11.023. Epub 2021 Nov 17. J Thorac Cardiovasc Surg. 2023. PMID: 34876283
-
A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.J Thorac Cardiovasc Surg. 2018 May;155(5):1978-1988.e1. doi: 10.1016/j.jtcvs.2017.11.112. Epub 2018 Feb 2. J Thorac Cardiovasc Surg. 2018. PMID: 29454487
-
One-Year Outcomes of a European Transcatheter Aortic Valve Implantation Cohort According to Surgical Risk.Circ Cardiovasc Interv. 2019 Jan;12(1):e006724. doi: 10.1161/CIRCINTERVENTIONS.118.006724. Circ Cardiovasc Interv. 2019. PMID: 30630356
-
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.Eur Heart J. 2019 Oct 7;40(38):3143-3153. doi: 10.1093/eurheartj/ehz275. Eur Heart J. 2019. PMID: 31329852
-
Three-Year Survival Comparison Between Transcatheter and Surgical Aortic Valve Replacement for Intermediate- and Low-Risk Patients.Innovations (Phila). 2018 May/Jun;13(3):153-162. doi: 10.1097/IMI.0000000000000507. Innovations (Phila). 2018. PMID: 29912140 Review.
References
-
- Nederlandse Vereniging voor Thoraxchirurgie en Nederlandse Vereniging voor Cardiologie. Indicatie Richtlijn TAVI 2020. https://www.zorginstituutnederland.nl/publicaties/publicatie/2020/11/18/...
-
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–532. - PubMed
-
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:E72–E227. - PubMed
Publication types
LinkOut - more resources
Full Text Sources